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Abstract: 
 Recently, the Kim Lab has shown that the cystic fibrosis transmembrane 
conductance regulator (cftr) gene is responsible for mediating resistance to Pseudomonas 
aeruginosa in a zebrafish infection model. Using the Gene Expression Omnibus, an 
NCBI functional genomics data repository, it was determined that Smad3, a transcription 
factor in the TGF-β signaling pathway, is upregulated in the presence of P. aeruginosa. It 
was found that in our zebrafish model, the Smad3 paralogs Smad3a and Smad3b are 
upregulated following microinjection of a cftr antisense morpholino oligomer. It was also 
found that microinjection of Smad3a and Smad3b morpholinos, along with a Smad2 
morpholino, and subsequent infection with Pseudomonas aeruginosa resulted in an 
increase in death, indicating that Smad3 has a protective effect against infection.  
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THESIS INTRODUCTION: 
The goal of this thesis is to further investigate and characterize cystic fibrosis 
(CF), an autosomal recessive multi-organ disease that is the result of a mutation in the 
cftr gene. The cftr mutation results in a nonfunctional form of a chloride channel that is 
essential for maintaining an ion balance within multiple organs. As a result of this cftr-
related imbalance, many functional problems can occur in these organs. A characteristic 
condition in patients with cystic fibrosis is thick mucus in the respiratory tract that 
becomes prime breeding ground for bacteria (12, 18, 27).  
The cftr mutation also affects the innate immune system, the part of the immune 
system that is the first to respond to infection. Because of this deleterious effect on the 
innate immune system, patients with cystic fibrosis are especially susceptible to bacterial 
infection. A pathogen that exhibits unusually high levels of infectivity in cystic fibrosis is 
Pseudomonas aeruginosa, a bacterium that is able to colonize the mucus of cystic fibrosis 
patients due to its anti-phagocytic activity and resistance to antimicrobials (12, 22). 
Further characterization of cftr is necessary in order to determine why it is only 
Pseudomonas aeruginosa that exhibits this high level of bacterial burden. 
We are interested in characterizing some of the other genes that are also affected 
by this cftr mutation. The Kim Lab is involved in a collaborative effort to retrieve a list of 
candidate genes that are affected by the cftr mutation, Pseudomonas aeruginosa 
infection, and arsenic exposure. Since these data are not yet available, previously 
published data was used to investigate the link between the cftr mutation and 
Pseudomonas aeruginosa infection. While amassing my own list of candidate genes, I 
2 
 
identified Smad3, a transcription factor that is instrumental in regulating genes in the 
TGF-β signaling pathway, as a possible candidate gene. I wanted to investigate how the 
cystic fibrosis condition or bacterial infection could play a role in the expression levels of 
Smad3. Conversely, I wanted to investigate the effects of knocking down Smad3 in 
conjunction with a Pseudomonas aeruginosa infection.  
 
LITERATURE REVIEW: 
Danio rerio as a model organism 
 The zebrafish, Danio rerio, is a freshwater fish that has become increasingly 
exploited as a model organism. The development of zebrafish as a model organism began 
in the 1970s, when George Streisinger was looking for a vertebrate model to study the 
development of the nervous system, as well as to examine mutation-based genetic 
analysis. Zebrafish have a low cost of maintenance, ease of maintenance, and have large 
clutch sizes (11). 
The genome of Danio rerio has been sequenced and has a high degree of gene 
similarity to Homo sapiens (6). Due to this similarity, human diseases like cystic fibrosis, 
muscular dystrophy, and several types of organ diseases, can be studied in the zebrafish 
model. Zebrafish has particular usefulness as a model organism in the studies of the 
innate immune system because it takes the zebrafish about 4 weeks to develop an 
adaptive immune system. Therefore, it is possible to look exclusively at the innate 
immune system (6, 32). Another advantage of the zebrafish as a model organism is its 
ability to be genetically modified in order to display certain characteristics, such as GFP-
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tagged neutrophils. Antisense RNA technologies like morpholino oligomers are also used 
in the zebrafish model, in which a loss of function effect can be produced either by 
knocking down translation or blocking the splicing of the mRNA (34).  
Zebrafish are useful for infection models like Pseudomonas aeruginosa, where 
both localized and systemic infections can be observed. One of the most defining features 
of using the zebrafish as a model for bacterial infection is its optical clarity, and the 
ability to look at infection real-time.  Its optical clarity is important for certain injections, 
including into the Duct of Cuvier and into the hindbrain. Real-time analysis pertains to 
the idea that during the first week post fertilization, infections can be visualized in situ 
using fluorescent proteins on the bacterium (35). 
 
Cystic Fibrosis and the cftr gene 
 Cystic fibrosis is among the most common genetically inherited diseases in the 
world, primarily affecting those of European descent. It is the most common lethal 
autosomal recessive disease in the white population, and affects about 1 in 3500 
Americans (27). Cystic fibrosis is caused by a mutation in the cystic fibrosis 
transmembrane conductance regulator (cftr) gene, which codes for the CFTR protein, a 
chloride channel that resides in the cell membrane of epithelial cells. The most common 
change to this gene is F508del, a deletion of the nucleotides CTT in the gene, causing the 
loss of phenylalanine from the protein (27). There are a number of other mutations that 
can lead to cystic fibrosis, and some appear to be more prevalent in different populations. 
Due to the deletion of phenylalanine, the protein will misfold and be targeted for 
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degradation by the ubiquitin-proteasome pathway. Therefore, it will never reach the cell 
membrane (36). Other mutations of cftr can result in the protein reaching the cell 
membrane, but it will not be entirely functional (1, 3).  
 The CFTR protein is a chloride channel that is present in epithelial cells and is 
responsible for the conductance of chloride in and out of these cells (Figure 1). CFTR is a 
member of the ATP binding cassette protein family, in which the defining characteristics 
of this family are two membrane spanning helices and two nucleotide binding domains. 
The phenylalanine deletion in cftr occurs in the region of the gene corresponding to 
nucleotide binding domain one (NBD1). CFTR also contains a regulatory domain, 
making it unique among the ABC proteins (15). When unphosphorylated, the regulatory 
domain has a disordered shape, and prevents dimerization of NBD1 and NBD2, an action 
that is necessary to open the channel. When phosphorylated, the R domain assumes a 
more orderly structure, and allows for dimerization of NBD1 and NBD2 (2). 
Phosphorylation of these dimerized domains allows for the passing of chloride through 
the channel.  
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Figure 1. The CFTR channel as it is shown in an epithelial cell membrane. 
Phosphorylation of the R domain, NBD1, and NBD2 are all required in order to open the 
channel for chloride passage.  
The CFTR protein is present in epithelial cells such as lung, liver, pancreas, and 
skin cells. The F508del mutation has a devastating effect on airway epithelial cells, where 
if it is not present to transport chloride across the cell membranes, a sodium-chloride ion 
imbalance results (33). This imbalance also affects the water content in these airways, 
affecting airway surface liquid, mucus transport, and will also result in thick mucus as a 
result of mucus dehydration. Thick mucus clogging the airways is one of the most 
common characteristics of cystic fibrosis, and it is very difficult for the cilia of these 
epithelial cells to clear this mucus from the airways. This mucus becomes an optimum 
media for pathogens like Pesudomonas aeruginosa to inhabit and colonize. Constant 
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infection and inflammation can lead to complications like pneumothorax, hypertension, 
and eventually death (18). 
Currently, there is no cure for cystic fibrosis, but treatments and therapies are 
available to help lessen the complications that come with the disease. There are drugs 
available, such as Kalydeco 
TM
 that can help people with the G551D mutation in the cftr 
gene. In this condition, the protein is transported to the membrane, but does not function. 
This drug helps to activate the NBDs and R domain to allow chloride transport. There are 
ongoing clinical trials with other drugs to investigate a treatment for F508del. Other 
treatments and therapies include antibiotics, chest physiotherapy, and mucus thinners (9).  
 
Pseudomonas aeruginosa 
 Pseudomonas aeruginosa is an opportunistic pathogen that is particularly invasive 
and problematic in patients with cystic fibrosis. It is a Gram-negative bacterium, with a 
membrane that has very low permeability, allowing it to have exceptional resistance to 
many antimicrobial drugs. Pseudomonas aeruginosa has the ability to secrete virulence 
factors via the Type III secretion system, where it relies on contact with epithelial cells. 
Such virulence factors lead to altered immune responses and cell death (8).  
 Pseudomonas aeruginosa has a limited number of porins, as well as a number of 
secondary mechanisms to prevent death of the cell. Secondary mechanisms, such as β-
lactamase production and overexpression of efflux pumps, combine with the low 
permeability of the membrane to ensure that antibiotics are unable to act upon the 
organism. Also, mutations can lead to either increased resistance or increased 
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susceptibility to these antibiotics, although typically such mutations would lead to 
something like the overexpression of efflux pumps and reduced uptake (4). In addition to 
mutations, horizontal gene transfer via transposons and plasmids will also confer 
additional resistance to Pseudomonas aeruginosa populations. In these gene transfers, 
targets of antibiotics will usually be modified slightly in order for them to be 
unrecognizable by the antibiotics (4, 8). 
 In patients with cystic fibrosis, the link between antibiotic resistance and 
virulence often leads to respiratory failure and lethal complications. A hallmark 
characteristic of Pseudomonas aeruginosa is the formation of biofilms, in which a 
congregation of cells grows to create a community of antibiotic resistance, as well as 
increased resistance to the natural immune system mechanisms from the host. One of the 
most important aspects for chronic Pseudomonas aeruginosa infection is its ability to 
switch classes, from the biofilm, or mucoid, form of growth to the nonmucoid form of 
growth (Table 1). Each class has its own specific advantages, ranging from anti-
phagocytic activity to antimicrobial resistance. (8, 12)
 
Table 1. The above table shows the advantages between each phenotype, and how 
it is particularly advantageous to switch between these phenotypes.  
In the cystic fibrosis condition, airway mucus becomes thicker and is harder to 
clear from the airways by cilia. This mucus becomes an ideal colonization medium for 
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Pseudomonas aeruginosa. The formation of biofilms in patients with cystic fibrosis in 
this mucus exacerbates inflammation and airway blockage, causing respiratory damage 
Chronic inhabitation of these airways by the bacteria results in an overzealous neutrophil 
response, leading to an increase in respiratory tract damage. Constant infection results in 
the activation of pro-inflammatory cytokines, such as IL-8, and other pro-inflammatory 
elements, such as ICAM-1. Neutrophil elastase is directly responsible for damaging the 
airway wall by degrading elastin. Reactive oxygen species and defensins are meant to 
help clear the infection, but end up being contributors to the scarring of the lung tissue.  
Respiratory failure eventually results due to constant infection (7, 33).  
 
The Innate Immune System 
 The immune system is a collection of different types and systems that are in 
cooperation to ward off infections by bacteria and viruses. It can be broken up into the 
innate and adaptive immune systems, where innate immunity is primarily composed of 
non-memory related cells, while adaptive immunity has the capability to recognize a 
returning pathogen or infection, and a quicker, more specific defense can be launched 
(Table 2) (21).  
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 Innate Immunity Adaptive Immunity 
Components and Cells 
Involved 
Physical and Chemical 
Barriers 
Phagocytic leukocytes 
Dendritic Cells 
NK Cells 
Cell Mediated Immunity via 
T Cells 
Humoral Immunity via B 
Cells 
Response Time Immediate  Much slower (days) 
Specificity General Very specific to certain 
antigens 
Memory No Yes –  memory B Cells 
have the ability to 
“remember” previous 
antigens 
 
Table 2. The comparisons between innate and adaptive immunity (21, 23). 
  
 Although the innate immune system is not more specific than the adaptive system, 
it does provide the first line of defense for the body. This line of defense comes primarily 
in the form of mast cells, macrophages, neutrophils, natural killer cells, and dendritic 
cells (23). Each of these types of cells can perform different functions, whether it is 
phagocytosis, the release of certain inflammatory cytokines, or the recruitment of other 
members of the immune system. Together, the cells of the innate immune system are able 
to form a comprehensive first line of defense, while the more specific adaptive immune 
system is given time to react. 
 Some of the first responders to a site of infection are the neutrophils, which act to 
defend the body by phagocytosis and the release of various cytokines and granules (7, 
33). The way in which neutrophils and other macrophages differ is through the presence 
of granules in neutrophils, which contain various enzymes like lysozyme, 
myeloperoxidase, and NADPH oxidase (21, 23). Neutrophils and macrophages are able 
to recognize their targets to be phagocytized is by the utilization of pattern recognition 
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receptors (PRRs). PRRs recognize and bind to pathogen-associated molecular patterns, 
PAMPs. Common PRRs include the Toll-like receptors (TLRs), mannose receptors, 
CD14, which is primarily found on macrophages, and NOD-like receptors, among others 
(21). 
 The TLR family of receptors contains multiple members, all of which are capable 
of recognizing different bacterial of virus components (Figure 2). TLRs are 
transmembrane receptors that contain a leucine rich repeat domain responsible for 
recognition of PAMPs, as well as an intracellular domain that is responsible for signal 
transduction. Some of the molecules that are recognized by TLRs include flagellin, 
lipopolysaccharide, ssDNA, and peptidoglvcan (21). Toll-like receptor 4 is responsible 
for recognizing lipid A, a component of the cell wall of Pseudomonas aeruginosa. 
Recognition of this lipid results in a pro-inflammatory response, which includes the 
release of various cytokines and chemokines that can increase blood flow, induce 
proliferation of immune cells, and recruit neutrophils to the site of infection (5, 10). Toll-
like receptor 5 is another TLR responsible for the recognition of Pseudomonas 
aeruginosa. TLR5 is able to identify flagellin, the subunit that makes up the flagellum of 
Psuedomonas aeruginosa (22, 30).  
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Figure 2. Shown are mammalian TLRs with known ligands, represented as they would be 
displayed on the cell surface (30). 
 In response to a component like LPS or other bacterial-specific molecules, a 
series of inflammatory events occur in order to reduce the potential hazardous effects of 
the pathogen. In particular, IL-1, IL-6, IL-18, IL-12, and TNFα can all work together to 
increase the inflammatory response. Such a response would increase body temperature 
thereby reducing the capability of the pathogen to replicate, as well as increase the 
migration of neutrophils and other macrophages to the site of infection via chemotaxis 
(21).  
 
TGF-Beta Signaling Pathway 
 The transforming growth factor beta, or TGF-β, signaling pathway is an integral 
part of cell signaling within the cell. The TGF-β pathway is host to a number of different 
functions through ligand-activation of receptors on the cell membrane, phosphorylation 
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of transcription factors called Smads, and shuttling of these Smad transcription factors to 
the nucleus to regulate gene transcription (Figure 3). Among the notable functions of the 
TGF-β signaling pathway are regulation of the cell cycle and apoptosis, as well as 
immunosuppression and inflammatory and anti-inflammatory cytokine regulation (13, 14, 
25, 26).  
 
 Figure 3. An overview of the TGF-β pathway. The binding of ligands to their 
appropriate receptor results in phosphorylation of Smad transcription factors. These 
transcription factors are shuttled to the nucleus, where they bind target DNA and result in 
the transcription of that gene (13). 
 The pathway begins with the binding of a ligand to the TGF-β receptors found on 
the cell membrane. These ligands consist of two different families: the TGF-
β/Activin/Nodal family of ligands and the BMP/GDS/MIS family of ligands. Although 
each family, and each ligand itself, elicits a different response, they are characterized by 
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6 cysteine residues within the ligand. The role of these cysteine residues is to form 
intramolecular and intermolecular disulfide bridges. All of the TGF-β ligands exist in a 
pro-peptide form that is cleaved into the mature form. The function of the pro-peptide can 
vary between the different ligands, but primarily, it exists to serves as a scaffolding 
protein. It can also play a role in ligand stability (25). These ligands are shuttled to the 
cell membrane of target cells, where TGF-β receptors await to receive and transduce the 
message.  
 There are two different families of TGF-β receptors, the type I receptors and type 
II receptors. The BMP family of ligands shows high specificity for type I recptors, and 
low specificity for type II, while the TGF-β family typically only interacts with type II 
(31). The receptors are made up of an extracellular N-terminus domain, which binds the 
ligand, a transmembrane domain, and an intracellular C-terminus domain. Unique ligand 
binding domains on the surface of type I and type II receptors ensure that the proper 
ligands are bound to the right receptor. BMP homodimers interact with their type I 
receptor via hydrophobic interactions. TGF-β ligands also form homodimers, forming 
large receptor complexes with type II receptors, followed by complexing with type I 
receptors (31). 
 Upon binding of TGF-β ligands to the type II receptor, an interaction between 
type I and type II receptors occurs (Figure 4).  A key structural difference between the 
two types of receptors is that the type I receptor contains a glycine-serine (GS) domain at 
its C-terminus, which is important for the type I/type II receptor interaction. Type II 
receptors contain a serine/threonine kinase domain at their C-terminus, which targets 
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serine and threonine residues in the C-terminus of type I receptors, specifically the 
TTSGSGSG sequences in this domain (26, 31).   
   
 
 
 
 
 
 Figure 4. The TGF-β ligand (blue and cyan) forms a homodimer that initially 
binds to the type II receptor ligand binding ectodomain (yellow). Then, it is able to also 
bind to the type I receptor (purple), forming the large receptor complex. The binding and 
proximity of the type I and type II receptors allows for phosphorylation and signal 
transduction (31). 
 A phosphorylated type I receptor also acts as a kinase, phosphorylating 
transcription factors called Smads. In humans, there are 8 Smad proteins, belonging to 3 
different families, consisting of receptor-activated Smads 1, 2, 3, 5 and 8, co-Smad4, and 
inhibitory Smad7 (26). Structurally, Smad proteins have 2 conserved domains. The MH1 
domain is the N-terminal domain, and is primarily responsible for sequence-specific 
DNA recognition. The MH2 domain, at the C-terminus, directly interacts with nuclear 
pores, allowing access into the nucleus. It also regulates oligomerisation with other 
Smads (26). An SxS motif in the MH2 domain is critical for receptor recognition.  
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Phosphorylation of this domain by the type I receptor is required for Smads to be 
translocated to the nucleus. Disruption of this motif would result in altered levels of 
Smad signaling (26). 
 R-Smads are recognized by the type I receptor kinase by two structural 
characteristics. A basic patch of amino acids on the surface of R-Smads allows for 
binding of the phosphorylated GS domain on the type I receptor to Smad (26). The 
specificity of binding results from the interaction between the L45 loop of the type I 
receptor and the L3 loop of R-Smads (31). As a result, TGF-β receptors only recognize 
Smad2 and Smad3, while BMP receptors recognize Smad1, Smad5, and Smad8. The 
specificity within the receptors comes down to matching sets of receptor loop L45 and 
Smad loop L3. Smads can be localized at the cell membrane next to TGF-β receptors by 
the Smad anchor for receptor activation, SARA. SARA binds to Smad2 or Smad3 via a 
hydrophobic surface region (31). 
 Once localized to the membrane, Smad is ready to be phosphorylated by TGF-
βR1. Phosphorylation of the SxS motif in the MH2 domain of R-Smads results in 
dissociation from SARA. This phosphorylated motif is then able to interact with other 
Smad proteins, either forming homomers or heteromers. Smad3 will also associate with 
Smad4, the co-Smad, in order to assist with translocatation to the nucleus (37). All of the 
Smads contain their own nuclear localization sequences, which are able to bind to 
specific importin proteins that transport them into the nucleus (26).  
 With the R-Smad in the nucleus, it is nearly ready to promote transcription of its 
target gene. Smads bind to DNA with sequence specificity. The Smad binding element, 
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located on the target DNA sequence, at minimum, requires the sequence 5’AGAC 3’, but 
will typically be recognized by Smad with additional bases on either end (Figure 5). R-
Smads achieve specific target DNA binding due to cell-type specific cofactors, including 
co-activators and co-repressors, as well as other Smads and DNA binding elements. The 
association of Smad to an array of molecules results in the transcription of specific genes 
(25).  
Figure 5.  A simplified diagram of Smad3 associating with Smad4 and other cofactors, 
binding to its target sequence in the promoter region. This gene would have transcription 
machinery recruited to it.  
  In short, Smad3, and all transcription factors, facilitate transcription of these 
target genes by binding to their target sequence in the promoter region of the target 
segment of DNA. Essentially, this will either promote or repress transcription of these 
genes by stabilizing or destabilizing the DNA, affecting the way in which RNA 
polymerase is able to bind to the DNA. In the case of Smad3, binding to its target gene 
will actively recruit transcription machinery to the target, resulting in the transcription 
and eventual translation of the gene.  
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 Smad signaling can be either positively or negatively regulated through direct 
competition for binding sites, as well as through the ubiquitin-dependent degradation 
pathway.  The direct competition for binding sites on TGFβ receptors, R-Smads or co-
Smad4, is achieved via binding by c-Ski, Smad6, or Smad7 (19). C-Ski negatively 
regulates Smad signaling by competing for the MH2 domain on Smad4. When 
interfering, a complete Smad complex is unable to form, and as a result, the transduction 
from the receptor is unable to continue. I-Smad7 does not directly interfere with any of 
the R-Smads, but instead acts by binding to TGFβR1, and in the process, inhibits 
phosphorylation of the R-Smads. Smad6 is able to bind to R-Smads, preventing the 
formation of a complete complex, similar to c-Ski (31). 
 Another method of inhibition is through a variety of ubiquitin-dependent 
degradation pathways, including the E3 ubiquitin ligases Smurf and APC. These ligases 
have target proteins that associate with the Smads, which can include c-Ski and SnoN. 
SnoN is able to activate the ubiquitin-mediated pathway of degradation by associating 
with the Smad that is to be degraded. SnoN can either downregulate or upregulate the 
pathway, depending on which Smad it binds to. It recruits Smurf1 and Smurf2, which are 
Smad ubiquitin regulatory factors.  These Smurfs induce degradation of R-Smads by the 
ubiquitin-proteasome pathway (13).   
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Targets of Smad3, the Immune System, and the Connection to Cystic Fibrosis 
 With the complexity and vastness of the TGF-β pathway being as large and 
encompassing as it is, it is no surprise that there are many targets of Smad3. Although 
targets of Smad3 and the TGF-β pathway usually play a role in cell cycle, apoptosis, or 
cytoskeleton rearrangement, there are still targets that can play either a direct or indirect 
role in the immune system. Among the most important targets of Smad3 in relation to the 
immune system are the anti-inflammatory cytokines IL-10 and RANTES, and the 
inflammatory cytokine IL-8 (14, 17, 19, 28). In normal lung epithelial tissue, the presence 
of TGFβ1 as a ligand and Smad3 would result in the upregulation of RANTES and 
downregulation of IL-8. The IL-8 promoter is Smad3-repressible; that is, when Smad3 is 
present, IL-8 will not be transcribed (17). But, previous studies have shown that the 
cystic fibrosis condition results in the knockdown of Smad3 in nasal epithelium. As a 
result, the anti-inflammatory cytokines for which it is responsible for regulating, IL-10 
and RANTES, are downregulated, and since Smad3 is not present, IL-8 is able to be 
transcribed, resulting in an increased inflammatory condition (17). 
Smad3 was found to target the gene responsible for encoding MARCKS, a protein 
that is responsible for actin rearrangement. This actin rearrangement helps to guide 
neutrophils to the site of infection (38).  Since Smad3 appears to be knocked-down in 
cystic fibrosis-affected nasal epithelial tissue, MARCKS would also be affected, lowering 
the rate at which neutrophils are able to migrate to the infection site. This would 
potentially decrease the overall ability of the immune system to clear the airways of 
pathogens like Pseudomonas aeruginosa. The importance of Smad3 in relation to the 
cystic fibrosis condition remains to be seen. But, altered levels of Smad3 would most 
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certainly affect its immune targets, thereby affecting the organism’s ability to handle and 
clear an infection.  
 
INTRODUCTION 
Cystic fibrosis is the most common autosomal recessive disorder in North 
America, affecting 1 in 3500 Americans (27). Under normal conditions, the cystic 
fibrosis transmembrane conductance regulator (CFTR) is responsible for chloride ion 
transport, and is found in the membranes of epithelial cells. In patients with cystic 
fibrosis, a mutation in the cftr gene exists. There are a multitude of mutations that can 
result in varying degrees of the disease, but the most common mutation is the F508 
deletion, in which the phenylalanine residue at position 508 is deleted. The F508 deletion 
that occurs in nucleotide binding domain 1 of CFTR results in the misfolding of the 
protein, and due to this mutation, the protein will never reach the plasma membrane. As a 
result of the mutation, chloride ion transport across these epithelial cell membranes is 
severely affected. It also indirectly affects sodium ion transport, as well as water balance 
(7, 24, 27).  
A characteristic condition resulting from the F508 deletion is thick and dry mucus 
due to the overall ion and water imbalance. This mucus becomes optimum breeding 
ground for many types of pathogens, particularly Pseudomonas aeruginosa (5, 29). 
Pseudomonas aeruginosa is problematic for patients with cystic fibrosis due to the 
bacterium’s low membrane permeability, as well as its ability switch back and forth 
between multiple forms. Its low membrane permeability allows for increased resistance 
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to antibiotics, and its ability to switch between nonmucoid and mucoid forms allows for 
phagocytic resistance. In those with the cftr mutation, Pseudomonas aeruginosa is the 
pathogen that has been reported to have the highest bacterial burden (29). It is not entirely 
known why the cftr mutation causes increased susceptibility to Pseudomonas aeruginosa 
and not other bacteria.  
In response to infection by Pseudomonas aeruginosa, the immune system 
responds with the migration of neutrophils. Neutrophils are granulocytic phagocytes that 
will release various degradative proteins in response to the infection. Such degradative 
proteins include elastase and lysozyme (22, 24). An overzealous immune response by 
these neutrophils results in scarring and inflammation in the lungs of cystic fibrosis 
patients. To help with the migration of neutrophils are various chemokines that can be 
released by cells that have come in contact with a foreign antigen (21). The regulation of 
some of these chemokines can be traced to the TGF-β signaling pathway. Although this 
pathway is more notorious for regulating process like cellular differentiation, apoptosis, 
and the cell cycle, some of its targets are immune related (13, 17).  
A key part of the TGF-β pathway is Smad3, a transcription factor that is 
translocated to the nucleus and is responsible for binding to the promoter region of genes 
to be regulated. The immune-related targets of Smad3 include IL-10, an anti-
inflammatory cytokine, and MARCKS, a protein that is responsible for actin cytoskeleton 
rearrangement to assist with neutrophil migration. Previous research has shown that the 
expression levels of Smad3 are altered in response to a knockdown of cftr¸ specifically in 
nasal epithelium (17). We are interested in whether Smad3 could play a protective role in 
defense against infection, and what its role in connection to cftr could be.  
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METHODS 
Identification of Novel Gene Targets using NCBI’s Gene Expression Omnibus 
Gene targets for characterization were identified using multiple databases through 
NCBI’s Gene Expression Omnibus tool. The databases selected for analysis and gene 
selection were: Bronchial epithelial cell line response to various airway pathogens 
(GDS2606), Airway epithelial cell response to Pseudomonas aeruginosa rsmA mutant 
infection (GDS2287), Cystic fibrosis patients with mild and severe lung disease: nasal 
respiratory epithelium (GDS2143), Cystic fibrosis and small intestine (GDS588) and 
Cystic fibrosis pancreatic gene expression (GDS567). Genes were selected based on their 
upregulation either in the presence of Pseudomonas aeruginosa infection or the presence 
of cystic fibrosis, depending on the database. 
 
Zebrafish Maintenance 
Zebrafish embryos were maintained in 50 mL of egg water (60 mg/L of Instant 
Ocean, Spectrum Brands, Madison, WI). Embryos were maintained at 28° C.  
 
Antisense Morpholino Injections 
Antisense morpholino oligonucleotide injections were performed on zebrafish 
embryos that were currently in the 1 cell stage (0.5-1 hpf). Cftr morpholino injections 
were performed with 3 nl, at 2.5 ng per embryo. Two different morpholinos were used: a 
splice blocker morpholino and translation blocker morpholino, as designed by Phennicie 
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et al (Table 3) (29) . Smad3a and Smad3b morpholinos were co-injected at 2 ng per 
embryo, along with a p53 morpholino at 12.5 ng, for a total injection volume of 3 nl. 
When performing Smad2, Smad3a, and Smad3b morpholino injections, 2 ng per embryo 
was once again used, with 18.75 ng of p53 per embryo. Smad2, Smad3a, and Smad3b 
morpholinos were designed by Jia et al (16). 
Gene Name Morpholino Sequence 
Cftr (Translation blocker) 5′-CCACCTGTAAATATTCAGAGCAGAT-3′ 
Cftr (Splice blocker) 5′-CATCCTCCACAGGTGATCTCTGCAT-3′ 
Smad3a 5’-TTCAGTTCAGCGTTCCTCTATTGC-3’ 
Smad3b 5’-GCAATATAGACATCTTTAGTTGAT-3’ 
 
Table 3. Morpholino antisense oligonucleotide design for 1 cell injections, as synthesized 
by Gene Tools (Philomath, OR).  
 
Bacterial Injections 
Wild-type Pseudomonas aeruginosa PA14 was grown overnight in LB broth at 
37° C. Liquid cultures were washed with phosphate-buffered saline, and cell density was 
determined using a spectrophotometer. Pseudomonas aeruginosa and PBS injections 
were performed 2 days post morpholino injection. To ensure a systemic infection, 
injections took place in the Duct of Cuvier. An injection volume of 3 nl was used for 250 
CFU and 1 nl for 150 and 90 CFU.  
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RNA Extraction and cDNA Synthesis 
RNA extraction was performed using the TRIzol phenol/chloroform extraction 
method (Invitrogen). RNA extractions were done in triplicate, with 10 fish in each 
replicate.  Fish were homogenized into the TRIzol reagent, which was followed by an 
incubation period of 3 min. with chloroform and centrifugation at 4° C for 15 min. at 
12000 g. RNA was isolated by adding 250 x linear acrylamide and 100% isopropanol to 
the aqueous phase, which was centrifuged at 15000 x g for 15 min. at 4° C. The RNA 
pellet was washed with 70% ethanol, spun at 15000 g for 5 min. and 4° C. The RNA 
pellet was resuspended into RNAse-free 10mM Tris-Cl, pH 8.0, and incubated at 50° C 
for 15 min. Extracted RNA was converted to cDNA using the iScript cDNA synthesis kit 
(BioRad, Hercules, CA).  
 
Quantitative PCR 
Target gene primers were designed using Primer3 for quantitative PCR (Table 4). 
Fold induction values were determined using a CFX96 real-time detection system with 
cDNA synthesized from control morpholino and cftr morpholino injected embryos and 
SsoFast EvaGreen as the fluorescent dye for detection of expression (BioRad, Hercules, 
CA).    
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Gene name Forward Primer (5’-3’) Reverse Primer (5’-3’) 
Smad3a GCA ACT ACA TAC CAG 
AGA CGC C 
TGG AGA ACC TGT GTC 
CAT GC 
Smad3b TGG ACA CAG GTT CTC 
CAA CG 
TGG TTG TGA GGC ATG 
GAA AG 
Vrk3 TGA ACC TTC ACC GCA 
ACA AG 
 
GAG GAG TCC CCA 
GCA CAA TC 
Ptpn2a TGG AGG AGG CTC 
AAA GAA GG 
TTG GAA CCC TGT TCC 
CAA AC 
Ptpn2b CTG GTT GAC ACT TGT 
CTT GTC TTG 
TCT CGC CAT TGT TTC 
TGC AC 
 
Table 4. List of primers designed for quantitative PCR. 
 
Cloning of Smad3a and Smad3b 
Smad3a and Smad3b were cloned using the following primers: Smad3a: 
CGTGAGAGACTGCGCAATAG (forward) and TACATTGGGCCAGATTTGTG 
(reverse). Smad3b was cloned using heminested primers, which comprised of: 
ATCATGCGGTGATGTGACTC (forward), GAGTCCAGAGGCTGTTTTGC (reverse, 
outside) and TGAGTGAGCACCTTGTCCAG (reverse, inside). cDNA was used from 
uninjected zebrafish. Desired genes were inserted into TOPO TA vectors (Invitrogen, 
Carlsbad, CA) and transformed into NEB competent cells (New England Biolabs, 
Ipswich, MA).  
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RESULTS 
Upregulation of Smad3a/Smad3b in cftr Morpholino Injected Whole Fish Tissue 
We wanted to investigate the effects that the cftr knockdown would have on the 
expression of our target genes. Quantitative PCR was performed using zebrafish that had 
been injected with the cftr morpholino. Analysis of gene expression in this whole fish 
tissue indicates that both Smad3a and Smad3b are upregulated in fish with lower 
expression levels of cftr (Figure 6). Smad3a shows a 1.36 fold induction, while Smad3b 
shows a 1.52 fold induction.   
 
Figure 6. Quantitative PCR graphs of cftr morpholino injected fish. The activity of target 
genes in cftr morpholino injected fish was measured in comparison to injection with a 
control morpholino. All samples were normalized to beta-actin levels of expression.  
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Gene Names 
Fold Induction of Target Genes 
Ptpn2a 
Ptpn2b 
Vrk3 
Smad3a 
Smad3b 
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Increased Death Associated with cftr Morpholino Injection in Conjunction with 
Pseudomonas aeruginosa Infection 
Phennicie et. al had previously performed bacterial burden studies with 
Pseudomonas aeruginosa using cftr morpholino injected fish. They had shown that the 
bacterial burden is higher in fish with the cftr knockdown (29). A mortality curve had not 
been published, so we aimed to produce a curve showing that this increased bacterial 
burden would correspond to an increase in death over control. An increase in death has 
been shown, consistent with the previous research suggesting that cftr knockdown has a 
negative-regulatory effect on the immune system (Figure 7).  
 
 
 
 
 
 
 
 
Figure 7. cftr knockdown and associated death in conjunction with Pseudomonas 
aeruginosa infection. Phennicie et al. had previously proven an increase in bacterial 
burden existed in fish with the cftr morpholino. Here it is shown that there is an increase 
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in death in morpholino injected fish with the infection at 150 CFU (unpublished data 
from Sullivan). Although there appears to be an increase in death, the P-value, as 
calculated by the Logrank test, is 0.1553, indicating there is this trend of death is not 
statistically significant.  
 
Increased Death Associated with Smad3a/Smad3b Morpholino Injected Fish along 
with Pseudomonas aeruginosa Infection 
Morpholinos of Smad3a and Smad3b were used to attempt to see if these genes 
had a role in survival of the fish upon infection with Pseudomonas aeruginosa. Embryos 
were also co-injected with a p53 morpholino to ensure that off-target effects of the 
Smad3a/3b morpholinos were not induced. After 1 day of infection, there was a 13% 
increase in death among the Smad3a/3b morpholino injected fish in comparison to 
control fish (Figure 8). Further experiments need to be performed in order to more 
accurately determine if there is a significant increase in death of these fish due to the 
morpholino knockdown, and not just due to infection.  
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Figure 8.The percent survival of morpholino and Pseudomonas aeruginosa injected fish 
with 250 CFU. Shown is the apparent increase in death after 1 day of infection, indicating 
that in the very short term, Smad3a and Smad3b knockdown may contribute to the 
increased death of the fish. This trend of increased death was proved to be insignificant, 
as calculated by the Logrank test, resulting in a P-value of 0.5214.  
We believe there to be a functional redundancy between Smad3 and Smad2, 
another transcription factor with similar roles in the TGF-β pathway. Another set of 
injections was performed, this time with the Smad2 morpholino included (Figure 9). 
These injections resulted in a 20% increase in death in morpholino injected fish after day 
1 and day 2 post infection.  
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Figure 9. The percent survival of fish also injected with the Smad2 morpholino, at 90 
CFU. In this graph, both the functional redundancy and amount of bacteria injected have 
been accounted for from the previous injection, resulting in a widened gap between 
control and morpholino injected fish. This trend was proved to be insignificant, as 
calculated by the Logrnak test, resulting in a P-value of 0.988. 
 
Identification of Smad3 Target Genes 
 Smad3 target genes were identified using GEO, in which regulated genes specific 
to the immune system were identified (Table 5) (38). Although this is not an exhaustive 
list of target genes, analysis of these selected genes via qPCR will be performed to 
determine their levels of expression in cftr morpholino injected fish or Pseudomonas 
aeruginosa infected fish.  
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Gene Function 
TACR1 Substance P binding, control of innate 
immunity 
WASPIP Responsiveness to IL-2 
Wdr34 TAK1-associated suppressor of the IL-
1R/TLR3/TLR4-induced NF-kappaB activation 
pathway 
PREP Regulation of IL-10 
YWHAZ Role in phagocytosis and microbial resistance 
TCF7 (Transcription factor 7 / T Cell Factor 1)Wnt 
pathway,  regulation of expression of IL-17 
MARCKS Regulation of neutrophil migration 
OPN3 Possible role in airway inflammation 
 
Table 5. A selective list of Smad3 target genes, as identified in “SMAD3 targets 
in A549 lung epithelial cells, GSE26858” (38).  
 
DISCUSSION 
Use of Bioinformatics to Determine Gene Targets 
 This study began with the analysis of various databases that contained gene 
expression data from various experimental conditions. By cross-referencing these 
databases and conducting further literature review, a selective list of target genes was 
created to investigate further (Table 4). The use of bioinformatics, microarrays and deep 
sequencing data is quickly becoming the most efficient method to look at gene expression 
on a large scale. The Kim Lab is currently in the middle of a collaborative effort to 
analyze gene expression from zebrafish that have been exposed to arsenic in conjunction 
with cftr knockdown and Pseudomonas aeruginosa infection. Once these data are 
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released, another comprehensive set of genes will be available that can offer further 
insight into the cystic fibrosis condition.  
 
Activity and Targets of Smad3 
We have found that expression levels of both Smad3 paralogs are upregulated in 
whole fish injected with the cftr morpholinos (Figure 6). It is also worth noting that 
Smad2 was found to be upregulated in the same database that Smad3 was identified from, 
further strengthening our theory of a functional redundancy. Based on these data, and 
with the knowledge that Smad3 has potential to regulate inflammatory and anti-
inflammatory responses, the increase in expression of Smad3 could be due to the need for 
more anti-inflammatory cytokines. IL-10, an anti-inflammatory target of Smad3 could be 
expressed to prevent an overzealous inflammatory reaction by the rest of the immune 
system (17). MARCKS, an actin rearranging protein, may also be upregulated to help 
with the migration of neutrophils to the site of infection (38). 
Previous research suggests that, in nasal epithelium with the expression of cftr 
knocked-down, Smad3 also is knocked down (17). It should follow that the previous anti-
inflammatory response described above would not occur in nasal epithelium tissues with 
the cftr knockdown. Instead, an increase in IL-8, an inflammatory cytokine, was observed 
in these tissues. The knockdown of cftr, and therefore Smad3, could play a role in 
exacerbating the inflammatory response in patients with cystic fibrosis by increasing the 
levels of IL-8 produced and decreasing the levels of IL-10 produced.  
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By recognizing that Smad3 has differential expression due to the cftr knockdown, 
it will be worthwhile to work with the targets of Smad3 to attempt to determine if these 
targets are also differentially expressed (Table 5). With the knowledge that a cftr 
knockdown also results in an increase in death, it is possible that the differential 
expression of these targets could contribute to this death. 
 
Using a Tetracycline Inducible Promoter to Examine Spatial and Temporal 
Expression 
In order to examine organ specific expression of Smad3 in zebrafish, tetracycline-
inducible promoter system will be utilized. Thanks to the Weidinger Lab, (Biotechnology 
Center and Center for Regenerative Therapies, Dresden, Germany) plasmids have been 
obtained containing promoters with the capability of being turned on and off in the 
presence or absence of tetracycline (20). A cftr promoter will be used in this plasmid to 
drive the expression of a dominant negative Smad3b gene. In the dominant negative 
Smad3b, the phosphorylation site that is necessary for translocation to the nucleus has 
been disrupted. Therefore, only tissue that contains the cftr gene will express dominant 
negative Smad3b. Desired experimental variables, such as the injection of the cftr 
morpholinos and Pseudomonas aeruginosa infections, will be applied in order to see the 
direct relationship between cftr and Smad3.  
The cftr mutation resulting in cystic fibrosis is known to compromise the immune 
system of these patients, although it has never been clearly identified how. Increased 
neutrophil presence in the airways and the increase of inflammatory cytokines are 
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normally signs of fighting an infection, but the vast majority of patients with cystic 
fibrosis still possess compromised immune systems. Pseudomonas aeruginosa is a 
bacterium that is able to take advantage of this condition, ultimately leading to death of 
the host. By further characterizing cftr and the genes affected by the mutation or 
Pseudomonas aeruginosa infection, it is hoped that therapies can be discovered and 
introduced to develop a cure for cystic fibrosis.    
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